Shares of Novavax (NASDAQ: NVAX) jumped on Tuesday on news of a major supply deal with the Japanese government. By the close of trading, the biotechnology company's stock price was up 7.6%.
Japan's Ministry of Health, Labour, and Welfare will buy 150 million doses of Novavax's COVID-19 vaccine candidate, subject to regulatory approval. The financial terms of the agreement were not disclosed.
Novavax struck a sizable coronavirus vaccine supply deal with Japanese health officials. Image source: Getty Images.
Source Fool.com